Sanofi
- Country
- 🇫🇷France
- Ownership
- Public
- Employees
- 87.9K
- Market Cap
- $141.3B
- Website
- http://www.sanofi.com
- Introduction
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescript...
SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism
- Conditions
- First Posted Date
- 2003-06-17
- Last Posted Date
- 2009-04-29
- Lead Sponsor
- Sanofi
- Registration Number
- NCT00062803
- Locations
- 🇺🇸
Loyola University Medical Center and Outpatient Clinic, Maywood, Illinois, United States
🇺🇸Akron General Medical Center, Akron, Ohio, United States
🇺🇸Mary Black Memorial Hospital, Spartanburg, South Carolina, United States
Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- Sanofi
- Registration Number
- NCT00012389
- Locations
- 🇺🇸
University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸Northwestern Medical Faculty Foundation, Chicago, Illinois, United States
🇺🇸Hematology Oncology Consultants Inc, Columbus, Ohio, United States
Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-11-15
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 3222
- Registration Number
- NCT00021255
- Locations
- 🇻🇪
Sanofi-Aventis Administrative Office, Caracas, Venezuela
Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)
- Conditions
- First Posted Date
- 2002-12-23
- Last Posted Date
- 2012-04-23
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 15603
- Registration Number
- NCT00050817
- Locations
- 🇬🇧
Sanofi-aventis Administrative Office, Guildford Surrey, United Kingdom
🇺🇸The Cleveland Clinic Foundation, Cleveland, Ohio, United States
Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment
- Conditions
- First Posted Date
- 2002-10-02
- Last Posted Date
- 2011-01-11
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 240
- Registration Number
- NCT00046462
- Locations
- 🇺🇸
Aventis, Bridgewater, New Jersey, United States
Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents
- Conditions
- First Posted Date
- 2002-10-02
- Last Posted Date
- 2011-01-11
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 250
- Registration Number
- NCT00046501
- Locations
- 🇺🇸
Aventis, Bridgewater, New Jersey, United States
12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.
- Conditions
- First Posted Date
- 2002-09-23
- Last Posted Date
- 2008-06-19
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 59
- Registration Number
- NCT00046150
- Locations
- 🇳🇱
Sanofi-aventis Administrative Office, Gouda, Netherlands
🇫🇷Hospital de Rangueil, Toulouse, France
Long-Term Safety Performance of Fexofenadine in Asthma
- Conditions
- First Posted Date
- 2002-09-19
- Last Posted Date
- 2008-08-21
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 1200
- Registration Number
- NCT00045955
- Locations
- 🇺🇸
Aventis Pharmaceutical Inc., Bridgewater, New Jersey, United States
Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma
- Conditions
- First Posted Date
- 2002-09-17
- Last Posted Date
- 2008-08-21
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 1000
- Registration Number
- NCT00044824
- Locations
- 🇲🇽
Sanofi-Aventis Administrative Office, Mexico, Mexico
🇨🇷Sanofi-Aventis Admnistrative Office, Costa Rica, Costa Rica
🇭🇺sanofi-aventis Hungaria, Budapest, Hungary
Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma
- Conditions
- First Posted Date
- 2002-09-17
- Last Posted Date
- 2008-08-21
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 1000
- Registration Number
- NCT00044811
- Locations
- 🇺🇸
Aventis Pharmaceuticals Inc., Bridgewater, New Jersey, United States
🇨🇷Sanofi-Aventis Admnistrative Office, Costa Rica, Costa Rica
🇷🇺Sanofi-Aventis Administrative Office, Moscow, Russian Federation